Finance

Lists
Why is PRTA down 2.14%?
Dive Deeper
PRTA:NASDAQ
Prothena Corporation PLC
$8.22
-2.14%
(-0.18) 1D
$8.20
-0.24% (-0.020)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRTA...
Open
$8.26
High
$8.47
Low
$8.07
Mkt. cap
422.10M
Avg. vol.
497.31K
Volume
861.98K
52-wk high
$11.80
52-wk low
$7.70
EPS
-$0.47
Beta
-0.20
Shares outstanding
51.35M
No. of employees
67
Open
$8.26
High
$8.47
Low
$8.07
Mkt. cap
422.10M
Avg. vol.
497.31K
Volume
861.98K
52-wk high
$11.80
52-wk low
$7.70
EPS
-$0.47
Beta
-0.20
Shares outstanding
51.35M
No. of employees
67
News stories
From web sources and news partners
About Prothena Corporation PLC
CEO-
Employees67
Founded2012
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to PRTA in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PRTA in the last 3 months.
Highest
Current $8.22
$36.00 (+337.96%)
Average
$21.75 (+164.60%)
Lowest
$8.00 (-2.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
$30.00
+265%
11/13/2026
Nevin Varghese
RBC Capital
Hold
Maintained
$13.00
+58.2%
11/05/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$36.00
+338%
11/06/2026
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
$8.00
-2.7%
11/06/2026
Brian Abrahams
RBC Capital
Hold
Maintained
$13.00
+58.2%
08/06/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$30.00
+265%
08/07/2026
Jason Butler
Citizens JMP
Buy
Maintained
$20.00
+143.3%
05/08/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$0.31 / -$0.30
-4.27%miss
Revenue / Est. (USD)
620.00K / 8.21M
-92.45%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
21.00K
51.08M
1.01M
620.00K
Cost of goods sold
14.59M
12.63M
8.80M
8.43M
Cost of revenue
14.59M
12.63M
8.80M
8.43M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.65M
12.67M
10.90M
10.59M
Operating expense
12.65M
12.67M
10.90M
10.59M
Total operating expenses
27.23M
25.29M
19.70M
19.02M
Operating income
-27.21M
25.79M
-18.69M
-18.40M
Other non operating income
-
-
-
-
EBT including unusual items
-21.58M
32.72M
-18.58M
-16.51M
EBT excluding unusual items
-24.59M
28.48M
-16.17M
-16.09M
Income tax expense
10.00K
1.00K
2.00K
2.00K
Effective tax rate
-0.05%
-
-0.01%
-0.01%
Other operating expenses
-
-
-
-
Net income
-21.59M
32.72M
-18.58M
-16.51M
Net profit margin
-102,804.76%
64.05%
-1,839.90%
-2,662.74%
Earnings per share
-0.46
0.68
-0.31
-0.31
Interest and investment income
2.65M
2.42M
2.55M
2.32M
Interest expense
-
-
-
-
Net interest expenses
2.65M
2.42M
2.55M
2.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.99M
25.98M
-18.49M
-18.19M
Gain or loss from assets sale
101.00K
-
5.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps